Pioneering CDM analysis sheds light on early detection, with cellular level precision, for patients with Mild Cognitive Impairment (MCI) compared to a Traditional MRI scan which only captures late stage atrophy with subjective intrepretation.
Pioneering CDM analysis sheds light on early detection, with cellular level precision, for patients with Mild Cognitive Impairment (MCI) compared to a Traditional MRI scan which only captures late stage atrophy with subjective intrepretation.